OBJECTIVE: Health-related quality of life (HRQOL) impairment may be a central component of chronic prostatitis for men afflicted with
this condition. Our objective was to examine HRQOL, and factors associated with HRQOL, using both general and condition-specific
instruments.
DESIGN: Chronic Prostatis Cohort (CPC) study.
SETTING: Six clinical research centers across the United States and Canada.
PARTICIPANTS: Two hundred seventy-eight men with chronic prostatitis.
MEASUREMENTS AND MAIN RESULTS: The Short Form 12 (SF-12) Mental Component Summary (MCS) and Physical Component Summary (PCS), and the National Institutes
of Health Chronic Prostatitis Symptom Index (NIH-CPSI) were measures used. CPC subjects’ MCS scores (44.0±9.8) were lower
than those observed in the most severe subgroups of patients with congestive heart failure and diabetes mellitus, and PCS
scores (46.4±9.5) were worse than those among the general U.S. male population. Decreasing scores were seen in both domains
with worsening symptom severity (P<.01). History of psychiatric disease and younger age were strongly associated with worse MCS scores, whereas history of rheumatologic
disease was associated with worse PCS scores. Predictors of more severe NIH-CPSI scores included lower educational level and
lower income; history of rheumatic disease was associated with higher scores.
CONCLUSIONS: Men with chronic prostatitis experience impairment in the mental and physical domains of general HRQOL, as well as condition-specific
HRQOL. To optimize the care of men with this condition, clinicians should consider administering HRQOL instruments to their
patients to better understand the impact of the condition on patients’ lives.
Key words prostatis - health-related quality of life
Presented in part at the American Urological Association National Meeting, Atlanta, Ga, May 2000.
This work was supported by grants from the NIH/NIDDK (Grant Nos. R01 DK53736, R01 DK53752, R01 DK53732, R01 DK53730, R01 DK53734,
and R01 DK53746). Dr. McNaughton Collins is a recipient of a Doris Duke Clinical Scientist Award.